The TRAIL to an anticancer agent

Drug Resistance Updates

Volumn 2, Issue 2, 1999, Pages 79-80

  El Deiry, Wafik S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CANCER CELL DESTRUCTION; CANCER THERAPY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0033022843     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.1999.0075     Document Type: Article

References (6)

1. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
2. Ashkenazi A., Dixit V. M. Death receptors: signalling and modulation. Science. 281:1998;1305-1308.
3. Wiley S. R., Schooley K., Smolak P. J. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 3:1995;673-682.
4. Ni J., Wei Y. F., Yu G., Gentz R., Dixit V. M. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science. 277:1997;815-818.
5. Sheridan J. P., Marsters S. A., Pitti R. M. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science. 277:1997;818-821.
6. Walczak H., Miller R. E., Ariail K. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nature Med. 5:1999;157-163.